Bulletin
Investor Alert

London Markets Open in:

Vectura Group PLC

LON: UK:VEC

GO
/marketstate/country/uk

Market closed

VEC
/zigman2/quotes/209600645/delayed

164.80

p

Change

-0.20 -0.12%

Volume

Volume 61,901

Oct 15, 2021, 4:35 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209600645/delayed

Previous close

165.00 p

164.80 p

Change

-0.20 -0.12%

Day low

Day high

164.60p

165.00p

Open
Open: 165.00

52 week low

52 week high

100.00p

176.00p

Open

Market cap

£1.00B

Average volume

11.01M

P/E ratio

8.19

Rev. per Employee

£379,681

EPS

0.20

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/uk/vec

MarketWatch News on VEC

  1. 42 Bargains in a Pricey Market

    9:09 a.m. July 20, 2021

    - Barron's Online

  2. U.S. Stocks Surge to New Records as Bond Yields Stabilize

    6:51 p.m. July 9, 2021

    - Barron's Online

  3. European stocks rebound from sharp selloff

    10:08 a.m. July 9, 2021

    - Barbara Kollmeyer

  4. GlaxoSmithKline shares outperform in FTSE 100

    1:22 p.m. March 18, 2010

    - Sarah Turner

  5. Deal eases fears of competition to GSK asthma drug

    10:52 a.m. March 18, 2010

    - Sarah Turner

  6. Vectura up 13.8% on Novartis deal

    3:14 a.m. April 13, 2005

    - Steve Goldstein

  7. Vectura, Aarakis in deal w/ Novartis on heart treatment

    2:43 a.m. April 13, 2005

    - Aude Lagorce

  8. Market for heart disease drug seen at $10B by 2010

    2:22 a.m. April 13, 2005

    - Aude Lagorce

  9. Current market for heart disease drug worth $4B a year

    2:21 a.m. April 13, 2005

    - Aude Lagorce

  10. Vectura, Arakis could get up to $172.5M each from deal

    2:21 a.m. April 13, 2005

    - Aude Lagorce

  11. Vectura, Arakis to each get initial $15M from deal

    2:19 a.m. April 13, 2005

    - Aude Lagorce

  12. Vectura, Arakis in deal w/ Novartis on heart drug

    2:18 a.m. April 13, 2005

    - Aude Lagorce

/news/nonmarketwatch/company/uk/vec

Other News on VEC

  1. Private-Equity Firms Spark Bidding Wars in U.K.

    6:38 p.m. July 25, 2021

    - The Wall Street Journal Interactive Edition

  2. Facebook, JPMorgan Chase, Netflix: Stocks That Defined the Week

    7:05 p.m. July 9, 2021

    - The Wall Street Journal Interactive Edition

  3. Philip Morris Buys Inhaled-Medicine Company Amid Health Push

    6:27 p.m. July 9, 2021

    - The Wall Street Journal Interactive Edition

  4. Glaxo Wins Injunction in Battle Over Asthma Drug

    9:28 p.m. March 23, 2014

    - The Wall Street Journal Interactive Edition

  5. Advair Poses Generic Hurdle

    3:33 p.m. Nov. 22, 2010

    - The Wall Street Journal Interactive Edition

  6. Asthma Drug Proves Hard for Generics to Match

    12:36 a.m. Nov. 22, 2010

    - The Wall Street Journal Interactive Edition

  7. Asthma Drug Proves Hard for Generics to Match

    8:04 p.m. Nov. 21, 2010

    - The Wall Street Journal Interactive Edition

  8. Advair Poses Generic Hurdle

    10:33 p.m. Nov. 28, 2010

    - The Wall Street Journal Interactive Edition

  9. Novartis Unit Buys Oriel Therapeutics

    9:30 p.m. April 19, 2010

    - The Wall Street Journal Interactive Edition

  10. A Note of Caution on Biotech Strategy

    2:33 p.m. April 5, 2010

    - The Wall Street Journal Interactive Edition

/news/pressrelease/company/uk/vec

Press Releases on VEC

Rates »

Trending Tickers
  • /zigman2/quotes/203240833/composite ASG-0.56%
  • /zigman2/quotes/200272047/composite OI-1.52%
  • /zigman2/quotes/201842100/composite DISCK-2.18%
  • /zigman2/quotes/208424563/composite GRFS-2.16%
  • /zigman2/quotes/202258849/composite COOP+2.03%
X
Powered by StockTwits
Link to MarketWatch's Slice.